18.97.9.170
dgid:
enl:
npi:0

-Advertisement-

-Advertisement-

Home Roundtable Takeaways, Part 1: Long-term Outcomes of VEGF-inhibitor use in AMD Management

Retina

Video

Roundtable Takeaways, Part 1: Long-term Outcomes of VEGF-inhibitor use in AMD Management

Posted on

Previous Article

The Current State of Research on Long-term VEGF Inhibitor Use

Next Article

Roundtable Takeaways, Part 2: Long-term Outcomes of VEGF-inhibitor use in AMD Management

-Advertisement-

Related Articles

Wearable collision warning device helps visually impaired individuals

Jul 22, 2021

Psoriasis linked with significantly higher risk of retinal diseases

Jul 20, 2021

Ranibizumab biosimilar has comparable efficacy, safety profile to reference product in patients with nAMD

Jul 19, 2021

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved

-Advertisement-

-Advertisement-

-Advertisement-

-Advertisement-